The Primary Health Care Limited (ASX:PRY) share price rose 5% to $3.72 this morning after the company released decent first half results – its first good result in a while. Here’s what you need to know: Revenues grew 6% to $856 million Underlying net profit after tax (NPAT) grew 5% to $44 million Statutory NPAT up 5% to $22 million (includes restructuring costs) Free cash flow almost doubled to $46 million Net debt reduced by $14 million to $770 million Earnings per share of 4.2 cents Dividends of 5.1 cents per share (paid out $30m, or 66% of free cash…
You can continue reading this story now by entering your email below
The Primary Health Care Limited (ASX:PRY) share price rose 5% to $3.72 this morning after the company released decent first half results – its first good result in a while. Here’s what you need to know:
- Revenues grew 6% to $856 million
- Underlying net profit after tax (NPAT) grew 5% to $44 million
- Statutory NPAT up 5% to $22 million (includes restructuring costs)
- Free cash flow almost doubled to $46 million
- Net debt reduced by $14 million to $770 million
- Earnings per share of 4.2 cents
- Dividends of 5.1 cents per share (paid out $30m, or 66% of free cash flow)
- Underlying NPAT guidance of $92 million to $97 million for the full year
- Outlook for continued pressure on funding
It was the first solid improvement for Primary in a while, with revenues, earnings, and cash flows all moving in the right direction. The company experienced $17 million in restructuring costs associated with redundancies, as well as investment in IT systems and other support systems in finance, property, and HR.
Earnings grew due to favourable pricing pressures as well as the opening of several new centres. Cash flow picked up strongly, however a significant contributor to this was lower capital expenditure. Given that Primary may have to invest further in its business in the future, it’s hard to say if current free cash flows are sustainable.
Despite the green shoots showing, Primary continues to sail pretty close to the wind in terms of its debt burden. Despite a reduction in dividend payments this half, company net debt barely moved and remains elevated at $770 million. This reflects a ‘gearing ratio’ of 2.52x, below the limit of 3.5x but still quite high for a struggling company.
Surprisingly, Primary continues to trade at around 20x full year underlying earnings, perhaps due to the market recognising the potential for cost reductions or further earnings growth. Even so I don’t think the company is stand-out value, and I’m not a buyer today.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Sean O'Neill has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.